FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2107988985> ?p ?o ?g. }

• W2107988985 endingPage "4793" @default.
• W2107988985 startingPage "4784" @default.
• W2107988985 abstract "Abstract Purpose: To examine the clinical utility of intratumor microRNAs (miRNA) as a biomarker for predicting responses to platinum-based doublet chemotherapy in patients with recurring lung adenocarcinoma (LADC). Experimental Design: The expression of miRNAs was examined in LADC tissues surgically resected from patients treated with platinum-based doublet chemotherapy at the time of LADC recurrence. Microarray-based screening of 904 miRNAs followed by quantitative reverse transcription-PCR–based verification in 40 test cohort samples, including 16 (40.0%) responders, was performed to identify miRNAs that are differentially expressed in chemotherapy responders and nonresponders. Differential expression was confirmed in a validation cohort (n = 63 samples), including 18 (28.6%) responders. An miRNA signature that predicted responses to platinum-based doublet chemotherapy was identified and its accuracy was examined by principal component and support vector machine analyses. Genotype data for the TP53-Arg72Pro polymorphism, which is associated with responses to platinum-based doublet chemotherapy, were subsequently incorporated into the prediction analysis. Results: A signature comprising three miRNAs (miR1290, miR196b, and miR135a*) enabled the prediction of a chemotherapeutic response (rather than progression-free and overall survival) with high accuracy in both the test and validation cohorts (82.5% and 77.8%). Examination of the latter was performed using miRNAs extracted from archived formalin-fixed paraffin-embedded tissues. Combining this miRNA signature with the TP53-Arg72Pro polymorphism genotype marginally improved the predictive power. Conclusion: The three-miRNA signature in surgically resected primary LADC tissues may by clinically useful for predicting responsiveness to platinum-based doublet chemotherapy in patients with LADC recurrence. Clin Cancer Res; 20(18); 4784–93. ©2014 AACR." @default.
• W2107988985 created "2016-06-24" @default.
• W2107988985 creator A5011448585 @default.
• W2107988985 creator A5016853321 @default.
• W2107988985 creator A5019998656 @default.
• W2107988985 creator A5020327537 @default.
• W2107988985 creator A5023176957 @default.
• W2107988985 creator A5025520229 @default.
• W2107988985 creator A5044502423 @default.
• W2107988985 creator A5050126669 @default.
• W2107988985 creator A5056637524 @default.
• W2107988985 creator A5063390528 @default.
• W2107988985 creator A5071187866 @default.
• W2107988985 creator A5071696225 @default.
• W2107988985 creator A5082354025 @default.
• W2107988985 creator A5089787707 @default.
• W2107988985 creator A5091148741 @default.
• W2107988985 date "2014-09-14" @default.
• W2107988985 modified "2023-10-18" @default.
• W2107988985 title "A Three-microRNA Signature Predicts Responses to Platinum-Based Doublet Chemotherapy in Patients with Lung Adenocarcinoma" @default.
• W2107988985 cites W1512280165 @default.
• W2107988985 cites W1648301895 @default.
• W2107988985 cites W1856690487 @default.
• W2107988985 cites W1974025003 @default.
• W2107988985 cites W1975096107 @default.
• W2107988985 cites W1979840428 @default.
• W2107988985 cites W1981083257 @default.
• W2107988985 cites W1989216370 @default.
• W2107988985 cites W1992845343 @default.
• W2107988985 cites W1997476230 @default.
• W2107988985 cites W1999851814 @default.
• W2107988985 cites W2010461414 @default.
• W2107988985 cites W2018336040 @default.
• W2107988985 cites W2024286449 @default.
• W2107988985 cites W2035213975 @default.
• W2107988985 cites W2037139573 @default.
• W2107988985 cites W2050249255 @default.
• W2107988985 cites W2063770678 @default.
• W2107988985 cites W2065799563 @default.
• W2107988985 cites W2066027374 @default.
• W2107988985 cites W2078564924 @default.
• W2107988985 cites W2090193893 @default.
• W2107988985 cites W2097760889 @default.
• W2107988985 cites W2099728256 @default.
• W2107988985 cites W2100082441 @default.
• W2107988985 cites W2102252487 @default.
• W2107988985 cites W2103427526 @default.
• W2107988985 cites W2105493915 @default.
• W2107988985 cites W2106787323 @default.
• W2107988985 cites W2120748646 @default.
• W2107988985 cites W2127343843 @default.
• W2107988985 cites W2127919472 @default.
• W2107988985 cites W2130808338 @default.
• W2107988985 cites W2132578211 @default.
• W2107988985 cites W2148332636 @default.
• W2107988985 cites W2151090489 @default.
• W2107988985 cites W2154284046 @default.
• W2107988985 cites W2155354546 @default.
• W2107988985 cites W2159241317 @default.
• W2107988985 cites W2166084034 @default.
• W2107988985 cites W2166399931 @default.
• W2107988985 doi "https://doi.org/10.1158/1078-0432.ccr-14-1096" @default.
• W2107988985 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6329384" @default.
• W2107988985 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25142144" @default.
• W2107988985 hasPublicationYear "2014" @default.
• W2107988985 type Work @default.
• W2107988985 sameAs 2107988985 @default.
• W2107988985 citedByCount "31" @default.
• W2107988985 countsByYear W21079889852015 @default.
• W2107988985 countsByYear W21079889852016 @default.
• W2107988985 countsByYear W21079889852017 @default.
• W2107988985 countsByYear W21079889852018 @default.
• W2107988985 countsByYear W21079889852019 @default.
• W2107988985 countsByYear W21079889852020 @default.
• W2107988985 countsByYear W21079889852021 @default.
• W2107988985 countsByYear W21079889852022 @default.
• W2107988985 crossrefType "journal-article" @default.
• W2107988985 hasAuthorship W2107988985A5011448585 @default.
• W2107988985 hasAuthorship W2107988985A5016853321 @default.
• W2107988985 hasAuthorship W2107988985A5019998656 @default.
• W2107988985 hasAuthorship W2107988985A5020327537 @default.
• W2107988985 hasAuthorship W2107988985A5023176957 @default.
• W2107988985 hasAuthorship W2107988985A5025520229 @default.
• W2107988985 hasAuthorship W2107988985A5044502423 @default.
• W2107988985 hasAuthorship W2107988985A5050126669 @default.
• W2107988985 hasAuthorship W2107988985A5056637524 @default.
• W2107988985 hasAuthorship W2107988985A5063390528 @default.
• W2107988985 hasAuthorship W2107988985A5071187866 @default.
• W2107988985 hasAuthorship W2107988985A5071696225 @default.
• W2107988985 hasAuthorship W2107988985A5082354025 @default.
• W2107988985 hasAuthorship W2107988985A5089787707 @default.
• W2107988985 hasAuthorship W2107988985A5091148741 @default.
• W2107988985 hasBestOaLocation W21079889851 @default.
• W2107988985 hasConcept C104317684 @default.
• W2107988985 hasConcept C121608353 @default.
• W2107988985 hasConcept C126322002 @default.
• W2107988985 hasConcept C135763542 @default.
• W2107988985 hasConcept C143998085 @default.

• next